AKOYA BIOSCIENCES INC (AKYA) Earnings History & Surprises

NASDAQ:AKYA • US00974H1041

1.29 USD
-0.07 (-5.15%)
At close: Jul 7, 2025
1.2899 USD
0 (-0.01%)
After Hours: 7/7/2025, 8:00:00 PM

Past quarterly earnings results for AKOYA BIOSCIENCES INC (AKYA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateAug 4, 2025
PeriodQ2 / 2025
EPS Estimate-$0.18
Revenue Estimate21.658M

Last Reported

Most Recent
Release DateMay 12, 2025
PeriodQ1 / 2025
EPS Reported-$0.32
EPS Surprise -53.04%
Revenue Surprise -18.23%

Beat Rate

Last 8 Quarters
38%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q1 2025 -0.32 -0.21 -53.04% 33.33% 16.639M 20.348M -18.23% -9.32%
Q4 2024 -0.17 -0.17 -2.56% 22.73% 21.344M 21.764M -1.93% -19.42%
Q3 2024 -0.21 -0.21 -1.05% 19.23% 18.814M 25.929M -27.44% -25.12%
Q2 2024 -0.27 -0.27 1.15% 41.30% 23.164M 24.023M -3.58% -1.52%
Q1 2024 -0.48 -0.29 -62.97% 2.04% 18.35M 24.767M -25.91% -14.29%
Q4 2023 -0.22 -0.27 19.69% 56.00% 26.487M 26.408M 0.30% 24.82%
Q3 2023 -0.26 -0.37 30.30% 44.68% 25.125M 25.031M 0.38% 33.29%
Q2 2023 -0.46 -0.45 -1.83% 2.13% 23.521M 22.887M 2.77% 31.48%
Q1 2023 -0.49 -0.49 0.51% -11.36% 21.41M 20.727M 3.30% 26.76%
Q4 2022 -0.50 -0.44 -14.00% -6.38% 21.22M 20.994M 1.08% 31.31%
Q3 2022 -0.47 -0.45 -4.72% -51.61% 18.85M 18.011M 4.66% 39.84%
Q2 2022 -0.47 -0.38 -23.87% -135.00% 17.89M 17.238M 3.78% 36.88%
Q1 2022 -0.44 -0.40 -11.32% 87.57% 16.89M 15.232M 10.88% 38.33%
Q4 2021 -0.47 -0.32 -48.64% - 16.16M 16.371M -1.29% 25.17%
Q3 2021 -0.31 -0.27 -14.69% - 13.48M 13.243M 1.79% 35.48%
Q2 2021 -0.20 -0.23 14.75% - 13.07M 12.818M 1.97% 52.69%
Q1 2021 -3.54 -0.17 -1,971.99% - 12.21M 12.269M -0.48% 10.80%
Q4 2020 - - 12.91M - -
Q3 2020 - - 9.95M - -
Q2 2020 - - 8.56M - -
Q1 2020 - - 11.02M - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

AKYA EPS Q2Q GrowthAKYA EPS Q2Q GrowthEPS Q2Q Growth Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 50 -50 -100

Revenue Historical Q2Q growth and Acceleration

AKYA Revenue Q2Q GrowthAKYA Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q3/21 Q1/22 Q3/22 Q1/23 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 0 20 -20 40

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
1
Average EPS beat (4)
-13.87%
Max EPS beat (4)
1.15%
Min EPS beat (4)
-53.04%

Revenue beat statistics

Revenue beat (4)
0
Average Revenue beat (4)
-12.79%
Max Revenue beat (4)
-1.93%
Min Revenue beat (4)
-27.44%

Analysis

In the last 4 quarters, AKYA has beaten EPS estimates in 1 out of 4 releases
AKYA has not beaten revenue estimates in any of the last 4 earnings releases
In the last 4 quarters, AKYA reported -13.9% below the EPS estimates on average.
In the last 4 quarters, AKYA reported -12.8% below the revenue estimates on average.
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

AKOYA BIOSCIENCES INC / AKYA Earnings FAQ

Can you provide the last earnings date for AKOYA BIOSCIENCES INC?

AKOYA BIOSCIENCES INC (AKYA) last reported earnings on 5/12/2025.


Did AKOYA BIOSCIENCES INC (AKYA) beat earnings estimates last quarter?

AKOYA BIOSCIENCES INC (AKYA) missed EPS estimates and missed revenue estimates in the most recent quarter.


How often does AKOYA BIOSCIENCES INC (AKYA) beat earnings estimates?

In the last 4 quarters, AKOYA BIOSCIENCES INC (AKYA) has beaten EPS estimates in 1 out of 4 releases.